Myovant Sciences and Pfizer Announce FDA Acceptance of Supplemental New Drug Application for MYFEMBREE® for the Management of Moderate to Severe Pain Associated With Endometriosis

Matt Turner
Patient Affordability

Stacey Gandler
Brand Nourishment

Paul Theisen
Patient Acquisition

Matthew Durham
Omnidynamic Marketing

Daniel Sontupe
Market Access

Suma Ramadas, PhD
Medical Affairs

Bud Bilanich
Success Coach

Amy Giles
Increasing Engagement

Brenda Snow
Authentic Patient Voice

Liz Kane
Impactful Strategy

Joey Cohen
Medication Adherence

Frank Burrell
Scientific Storytelling

David Linetsky
Point-of-Care Marketing

Pat Purcell
Meeting Engagement